Metformin Hydrochloride Eg (Eurogenerics)

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Eg, is a biguanide presented as an oral tablet for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus. By reducing hepatic glucose output and enhancing peripheral insulin sensitivity, it helps lower blood sugar levels.

GNH USA supplies Metformin Hydrochloride Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements across EU and global markets.

Metformin Hydrochloride is a biguanide antidiabetic agent used primarily in the management of type 2 diabetes mellitus.

- Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Prediabetes (impaired fasting glucose): delays progression to overt diabetes. - Gestational diabetes (when insulin is not required): assists in maintaining target glucose levels.

Metformin Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or pain. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hypoglycemia: when combined with other glucose‑lowering agents. - Vitamin B12 deficiency: may develop with long‑term use. - Hepatic dysfunction: abnormal liver enzymes. - Acute pancreatitis: very rare inflammatory pancreas condition.

Metformin Hydrochloride requires careful consideration of several clinical factors before and during therapy.

- Renal function: assess eGFR before initiating and monitor periodically. - Hepatic disease: use with caution in patients with liver impairment. - Risk of lactic acidosis: avoid in conditions predisposing to hypoxia or severe infection. - Alcohol consumption: limit intake to reduce acidosis risk. - Pregnancy and lactation: evaluate risk‑benefit ratio with the prescriber. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin Hydrochloride can interact with a variety of medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of renal impairment and lactic acidosis. - Cimetidine: may raise plasma metformin concentrations. - Alcohol: potentiates lactic acidosis risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - ACE inhibitors or ARBs: monitor renal function and potassium levels. - Thiazide diuretics: may attenuate glucose‑lowering effect. - Digoxin: observe for altered drug levels. - Warfarin: monitor INR as metformin may affect anticoagulation control.